Stella Sarraf

Fundador en Spinogenix, Inc. .

Health Technology

Commercial Services

Perfil

Stella Sarraf is the founder of Spinogenix, Inc. (founded in 2016) where she holds the titles of President, Chief Executive Officer & Director, and Amydis, Inc. (founded in 2013) where she holds the title of Chief Executive Officer & Director.

Cargos activos de Stella Sarraf

Empresas	Cargo	Inicio
Spinogenix, Inc. Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA.	Fundador	01/01/2016
Amydis, Inc. Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then.	Fundador	01/01/2013

Todos los cargos activos de Stella Sarraf

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Stella Sarraf.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	2
Spinogenix, Inc. Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA.	Health Technology
Amydis, Inc. Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then.	Commercial Services